Live symbol workspace

XLV market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $146.81

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$139.47

Resistance

$154.15

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$146.81

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for XLV skewed bullish (1 of 3 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

▼ 2.5 pts vs previous week

Avg confidence across 43 calls in the last 7 days

What sources say

Bullish 1 article

2 Healthcare Stocks to Consider Right Now and 1 We Brush Off

Bearish 1 article

Health Care ETFs: XLV Delivers Low Fees and Solid Returns

Neutral 1 article

The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

XLV News Intelligence (15 articles)

AI-curated news influencing XLV price, sentiment, and trend

Explore All XLV News with AI Analysis

Economy

2 months, 4 weeks ago

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the …

Impact on XLV: The healthcare sector's flat return over the past six months, compared to …

The healthcare sector has shown resilience with a flat return over the past six months, … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

3 months ago

1 Healthcare Stock on Our Watchlist and 2 We Find Risky

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory …

Impact on XLV: The 2.2% decline in the healthcare industry has mirrored the S&P 500's …

The healthcare industry has experienced a 2.2% decline over the past six months, mirroring the … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Stocks

3 months, 1 week ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease …

Impact on XLV: The announcement is likely to have a positive impact on Pfizer's (PFE) …

Pfizer and Valneva plan to seek regulatory approval for a Lyme disease vaccine after a … High (80%)

View full analysis →

MarketWatch 80% confidence